VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹136 Cr | ₹79 Cr | ₹83 Cr | ₹93 Cr | ₹97 Cr |
What is the latest Total Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹136 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹93 Cr |
| Mar2021 | ₹97 Cr |
How is Total Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹136 Cr | 71.61 | |
| Mar2024 | ₹79 Cr | -3.82 | |
| Mar2023 | ₹83 Cr | -10.97 | |
| Mar2022 | ₹93 Cr | -4.83 | |
| Mar2021 | ₹97 Cr | - | |
Compare Total Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,051.6 Cr | 9.3% | -0.6% | 151.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 9.3% |
-0.6% |
151.9% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses